Tyler B Wray1, Philip A Chan2, Christopher W Kahler1, Erik M Simpanen1, Tao Liu3, Kenneth H Mayer4. 1. Center for Alcohol and Addictions Studies, Brown University School of Public Health, Providence, RI. 2. Department of Medicine, Alpert Medical School of Brown University, Providence, RI. 3. Department of Biostatistics, Center for Statistical Sciences, School of Public Health, Brown University, Providence, RI. 4. Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
Abstract
BACKGROUND: Pre-exposure prophylaxis (PrEP) is highly efficacious, but some groups of men who have sex with men may have difficulty adhering to daily dosing. Prevention-effective adherence suggests that PrEP's efficacy depends on adherence at the time of HIV exposure; yet, few studies have examined how exposures (ie, high-risk sex) overlap with periods of consecutive missed PrEP doses. Substance use may also play a role in these vulnerable periods. METHODS: We used digital pill bottles to monitor the daily adherence of 40 PrEP-experienced patients recruited from an outpatient clinic in the Northeastern US over a six-month period. Participants also completed detailed online diaries every 2 weeks during this time that surveyed their sexual behavior and substance use each day. RESULTS: Daily adherence was high overall (M = 83.9%, SD = 18.0%), but 53% (N = 21) had a lapse of > 3 consecutive daily PrEP doses over 6 months. Participants' rate of engaging in high-risk condomless anal sex (CAS) did not differ across lapse days versus continuously adherent days. Alcohol use was not associated with engaging in CAS during a PrEP lapse. However, participants reported engaging in CAS significantly more often during a PrEP adherence lapse on days when they also used stimulant drugs. CONCLUSIONS: Men who have sex with men may have periodic difficulty adhering to PrEP at the specific times when they are at risk. Stimulant drug use could play an important role in increasing HIV risk specifically during adherence lapses.
BACKGROUND: Pre-exposure prophylaxis (PrEP) is highly efficacious, but some groups of men who have sex with men may have difficulty adhering to daily dosing. Prevention-effective adherence suggests that PrEP's efficacy depends on adherence at the time of HIV exposure; yet, few studies have examined how exposures (ie, high-risk sex) overlap with periods of consecutive missed PrEP doses. Substance use may also play a role in these vulnerable periods. METHODS: We used digital pill bottles to monitor the daily adherence of 40 PrEP-experienced patients recruited from an outpatient clinic in the Northeastern US over a six-month period. Participants also completed detailed online diaries every 2 weeks during this time that surveyed their sexual behavior and substance use each day. RESULTS: Daily adherence was high overall (M = 83.9%, SD = 18.0%), but 53% (N = 21) had a lapse of > 3 consecutive daily PrEP doses over 6 months. Participants' rate of engaging in high-risk condomless anal sex (CAS) did not differ across lapse days versus continuously adherent days. Alcohol use was not associated with engaging in CAS during a PrEP lapse. However, participants reported engaging in CAS significantly more often during a PrEP adherence lapse on days when they also used stimulant drugs. CONCLUSIONS:Men who have sex with men may have periodic difficulty adhering to PrEP at the specific times when they are at risk. Stimulant drug use could play an important role in increasing HIV risk specifically during adherence lapses.
Authors: Natalie M Leblanc; Hugh F Crean; Typhanye P Dyer; Chen Zhang; Rodman Turpin; Nanhua Zhang; Martez D R Smith; James McMahon; LaRon Nelson Journal: Arch Sex Behav Date: 2021-04-26
Authors: Michael Viamonte; Delaram Ghanooni; John M Reynolds; Christian Grov; Adam W Carrico Journal: Curr HIV/AIDS Rep Date: 2022-06-14 Impact factor: 5.495
Authors: Adam Viera; Jacob J van den Berg; Collette D Sosnowy; Nikita A Mehta; E Jennifer Edelman; Trace Kershaw; Philip A Chan Journal: AIDS Behav Date: 2022-03-18
Authors: Francis Lee; Daniel Sheeler; Anna Hotton; Natascha Del Vecchio; Rey Flores; Kayo Fujimoto; Nina Harawa; John A Schneider; Aditya S Khanna Journal: Int J Drug Policy Date: 2022-02-24
Authors: Rodman E Turpin; Typhanye V Dyer; Derek T Dangerfield; Hongjie Liu; Kenneth H Mayer Journal: Drug Alcohol Depend Date: 2020-06-26 Impact factor: 4.492